N/A N=158 Advanced MRI Sequences for Radiation Therapy Treatment Planning
Cancer
Primary: Number of Participants Successfully Contributing MRI Data — 158 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=53 Development of Walk Assist Device to Improve Community Ambulation
Stroke
Primary: Change in 10 Meter Walk Test From Baseline in Gait Speed — 0.7051; 0.6606; 0.8544; 0.7547 meters per second
Phase 4 N=24 Vilazodone for Separation Anxiety Disorder
Separation Anxiety Disorder
Primary: Clinical Global Impression-Improvement Scale — 7; 4 Participants — p=.064
Phase 2 N=106 S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
Colorectal Cancer
Primary: Progression-free Survival — 2.0; 4.3 months — p=0.001
Phase 2 N=250 Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
Diabetes Mellitus, Type 2
Primary: Mean Change From Baseline in Hemoglobin A1c (Glycosylated Hemoglobin) (HbA1c) at Week 12 — -0.19; -0.53; -0.75; -0.53 Percentage — p=0.003
Phase 3 N=13,885 A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Peripheral Artery Disease
Primary: Composite of Cardiovascular (CV) Death/MI/Ischemic Stroke — 751; 740 Participants — p=0.650
Phase 1 N=17 Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070)
Hepatic Insufficiency
Primary: Area Under the Concentration-time Curve of MK-0822 From Time 0 to Infinity (AUC0-∞) After Single Dose — 28.84; 33.79 μM*hr
Phase 3 N=128 Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
Iron Deficiency Anaemia · Inflammatory Bowel Disease · Crohn's Disease
Primary: Change in Haemoglobin (Hb) Concentration From Baseline to Week 12 (Full Analysis Set, FAS) — 2.26; 0.01 g/dL — p=< 0.0001
Phase 3 N=650 ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection
Hepatitis C Virus (HCV)
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment (SVR12) — 99.5; 100 percentage of participants
N/A N=150 HealthyMe Online Weight Management Education/HealthyMe at Home
Diabetes
Primary: Body Weight — -0.8; -1.5; -7.3 pounds
Phase 3 N=357 Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™
Infections, Streptococcal
Primary: Concentrations of Antibodies Against Vaccine Pneumococcal Serotypes — 2.69; 0.03; 3.44; 0.03 μg/mL
N/A N=35 Pilot Study of PEMF Therapy in Treatment of Post-operative Pain Following Total Knee Arthroplasty
Post-Operative Pain Following Total Knee Arthroplasty
Primary: Change in Pain Intensity — -30.9; -29.7 Units on a scale
Phase 2 N=40 Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
Obesity
Primary: Gastric Emptying of Solids Half-time (T1/2) at 5 Weeks — 180; 117 minutes
Phase 2 N=9 Vitamin D to Improve Endothelial Function in SLE
Atherosclerosis · Systemic Lupus Erythematosus
Primary: Change at Week 16 in % Flow Mediated Dilation in Those Who Did and Did Not Replete Vitamin D — 1.4; -4.2 Absolute change in % FMD — p=> 0.05
N/A N=350 Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Knee Osteoarthritis
Primary: Change From Baseline to Month 4 and Change From Baseline to 12 Month in Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Index Score — -6.73; -6.06…